Cite
HARVARD Citation
Davis, M. et al. (2016). Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition. BMC cancer. 16 (1), pp. 1-13. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Davis, M. et al. (2016). Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition. BMC cancer. 16 (1), pp. 1-13. [Online].